Literatur
-
1 Leitlinien zur Therapie mit Blutkomponenten und Plasmaderivaten. 3. überarbeitete und erweiterte Auflage. Köln; Deutscher Ärzte-Verlag 2003
-
2 Kaiser R. Persönliche Mitteilung. Bundesamt für Statistik. 2000
-
3 Richtlinien zur Gewinnung von Blut und Blutbestandteilen und zur Anwendung von Blutprodukten (Hämotherapie). Köln; Deutscher Ärzte-Verlag 2001
-
4
Birkmeyer J D, AuBuchon J P, Littenberg B, O’Connor G T, Nease R F , Nugent W C, Goodnough L T.
Cost-effectiveness of preoperative autologous donation in coronary artery bypass grafting.
Ann Thorac Surg.
1994;
57
161-168
-
5
Muirhead B.
Con: Preoperative autologous donation has no role in cardiac surgery.
J Cardiothorac Vasc Anesth.
2003;
17
126-128
-
6
Chamberland M E.
Emerging infectious agents: do they pose a risk to the safety of transfused blood and blood products?.
Clin Infect Dis.
2002;
34
797-805
-
7
Sonnenberg F A, Gregory P, Yomtovian R, Russell L B, Tierney W, Kosmin M, Carson J L.
The cost-effectiveness of autologous transfusion revisited: implications of an increased risk of bacterial infection with allogeneic transfusion.
Transfusion.
2000;
39
808-817
-
8
Vamvakas E C.
Transfusion-associated cancer recurrence and postoperative infection: meta-analysis of randomized, controlled clinical trials.
Transfusion.
1996;
36
175-186
-
9
Vamvakas E C, Blajchman M A.
Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction?.
Blood.
2001;
97
1180-1195
-
10 Henry D A, Carless P A, Moxey A J, O’Connell D, Forgie M A, Wells P S, Fergusson D. Pre-operative autologous donation for minimising perioperative allogeneic blood transfusion (Cochrane Review). In: The Cochrane Library, Issue 4, 2003 Chichester, UK; John Wiley & Sons, Ltd
-
11
Hay S N, Monk T G, Brecher M E.
Intraoperative blood salvage: a mathematical perspective.
Transfusion.
2002;
42
451-455
-
12
Goodnough L T, Despotis G J, Merkel K, Monk T G.
A randomized trial comparing acute normovolemic hemodilution and preoperative autologous blood donation in total hip arthroplasty.
Transfusion.
2000;
40
1054-1057
-
13
Sowade O, Warnke H, Scigalla P, Sowade B, Franke W, Messinger D, Gross J.
Avoidance of allogeneic blood transfusions by treatment with epoetin beta (recombinant human erythropoietin) in patients under-going open-heart surgery.
Blood.
1997;
89
411-418
-
14
Goodnough L T, Price T H, Rudnick S, Soegiarso R W.
Preoperative red cell production in patients undergoing aggressive autologous blood phlebotomy with and without erythropoietin therapy.
Transfusion.
1992;
32
441-445
-
15
Kasper S M, Gerlich W, Buzello W.
Preoperative red cell production in patients undergoing weekly autologous blood donation.
Transfusion.
1997;
37
1058-1062
-
16
Mercuriali F, Zanella A, Barosi G. et al .
Use of erythropoietin to increase the volume of autologous blood donated by orthopedic patients.
Transfusion.
1993;
33
50-60
-
17
Weisbach V, Skoda P, Rippel R, Lauer G, Glaser A, Zingsem J, Zimmermann R, Eckstein R.
Oral or intravenous iron as an adjuvant to autologous blood donation in elective surgery: a randomized, controlled study.
Transfusion.
1999;
39
465-472
-
18
Weisbach V, Corbière C, Strasser E, Zingsem J, Zimmermann R, Eckstein R.
The variability of compensatory erythropoiesis in repeated autologous blood donation.
Transfusion.
2001;
41
179-183
-
19
Goodnough L T, Price T H, Parvin C A.
The endogenous erythropoietin response and the erythropoietic response to blood loss anemia: the effects of age and gender.
J Lab Clin Med.
1995;
126
57-64
-
20
Goodnough L T, Marcus R E.
Erythropoiesis in patients stimulated with erythropoietin: the relevance of storage iron.
Vox Sang.
1998;
75
128-133
-
21
Kasper S M, Lazansky H, Stark C. et al .
Efficacy of oral iron supplementation is not enhanced by additional intravenous iron during autologous blood donation.
Transfusion.
1998;
38
764-770
-
22
Goodnough L T, Rudnick S, Price T H. et al .
Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy.
N Engl J Med.
1989;
321
1163-1168
-
23
Bezwada H P, Nazarian D G, Henry D H, Booth R E .
Preoperative use of recombinant human erythropoietin before total joint arthroplasty.
J Bone Joint Surg.
2003;
85
1795-1800
-
24
Casadevall N, Nataf J, Viron B, Kolta A, Kiladjian J J, Martin-Dupont P, Michaud P, Papo T, Ugo V, Teyssandier I, Varet B, Mayeux P.
Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin.
N Engl J Med.
2002;
346
469-475
-
25 PRCA Reports in Europe, Johnson & Johnson, 12 2003.
-
26 Weisbach V. Optimierung der präoperativen Eigenblutspende. Habilitationsschrift. Friedrich-Alexander-Universität Erlangen-Nürnberg, 2001.
-
27
Walther-Wenke G, Walker W H.
Establishment of the leucocyte - depleted autologous whole blood pack.
Anasthesiol Intensivmed Notfallmed Schmerzther.
2002;
37
686-689
-
28
Hess J R, Rugg N, Gormas J K, Knapp A D, Hill H R, Oliver C K, Lippert L E, Silberstein E B, Greenwalt T J.
RBC storage for 11 weeks.
Transfusion.
2001;
41
1586-1590
PD Dr. Volker Weisbach
Abteilung für Transfusionsmedizin und Hämostaseolgie · Universitätsklinikum Erlangen
Krankenhausstraße 12 · 91054 Erlangen
Email: Volker.Weisbach@trans.imed.uni-erlangen.de
